España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Exagen
XGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.15
0.44
9.34%
At close: -
$5.15
0.00
0.00%
After Hours: Dec 20, 4:17 PM EDT
Get Report
Comment
Exagen (XGN) Forecast
News
Earnings
Exagen (XGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Exagen (NASDAQ:XGN) Stock
Exagen Stock (NASDAQ: XGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 12, 2024
Exagen Reaches 1M Patient Tested By AVISE CTD...
Benzinga Newsdesk
Thursday, November 14, 2024
Exagen Reports Validation, Regulatory Submiss...
Benzinga Newsdesk
Tuesday, November 12, 2024
Exagen Q3 EPS $(0.28) Beats $(0.29) Estimate,...
Benzinga Newsdesk
Exagen Sees FY2024 Sales $55.000M-56.000M vs ...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, October 21, 2024
Exagen Announces Five Abstracts Accepted At 2...
Benzinga Newsdesk
Thursday, August 08, 2024
Exagen shares are trading higher after the co...
Benzinga Newsdesk
Monday, August 05, 2024
Exagen Increases FY24 Revenue Outlook To At L...
Benzinga Newsdesk
Exagen Q2 2024 GAAP EPS $(0.16) Beats $(0.34)...
Benzinga Newsdesk
Thursday, August 01, 2024
Exagen Appoints Jeffrey G. Black As New Chief...
Benzinga Newsdesk
Monday, June 10, 2024
Time to Play 5 Top-Ranked Stocks With Rising P/E?
Zacks
Tuesday, May 14, 2024
Cantor Fitzgerald Maintains Overweight on Exa...
Benzinga Newsdesk
Monday, May 13, 2024
Exagen Increases FY24 Revenue To At Least $55...
Benzinga Newsdesk
Exagen Q1 2024 GAAP EPS $(0.19) Beats $(0.36)...
Benzinga Newsdesk
Monday, March 18, 2024
Exagen shares are trading higher after the co...
Benzinga Newsdesk
Exagen Expects Q1 FY2024 Revenue Of $13M-$13....
Benzinga Newsdesk
Exagen Expects FY2024 Revenue Of Approximatel...
Benzinga Newsdesk
Exagen Q4 GAAP EPS $(0.31) Beats $(0.43) Esti...
Benzinga Newsdesk
Earnings Scheduled For March 18, 2024
Benzinga Insights
Friday, March 15, 2024
Earnings Outlook For Exagen
Benzinga Insights
Sunday, January 07, 2024
Exagen Inc. Announces Select Preliminary Full...
Benzinga Newsdesk
Friday, January 05, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, January 04, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, December 01, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, November 21, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, November 20, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, November 17, 2023
Exagen Inc Entered Into Amendment No. 1 To Th...
Benzinga Newsdesk
Exagen Inc Files For Mixed Shelf Of Up To $15...
Benzinga Newsdesk
Wednesday, November 15, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, November 14, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, November 13, 2023
Exagen Inc. Says FY23 Revenue Guidance Of At ...
Benzinga Newsdesk
Exagen Q3 2023 Gaap EPS $(0.31) Beats $(0.46)...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Preview For Exagen
Benzinga Insights
Thursday, November 09, 2023
Exagen Inc. And Johns Hopkins University Anno...
Benzinga Newsdesk
Tuesday, November 07, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Tuesday, October 17, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, October 06, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, October 05, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, September 26, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ex...
Benzinga Newsdesk
Tuesday, September 19, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Tuesday, August 22, 2023
Cantor Fitzgerald Reiterates Overweight on Ex...
Benzinga Newsdesk
Monday, August 07, 2023
Exagen Expects 3Q23 Revenue Of $10M-$10.5M Vs...
Benzinga Newsdesk
Exagen Q2 EPS $(0.28) Beats $(0.48) Estimate,...
Benzinga Newsdesk
Earnings Scheduled For August 7, 2023
Benzinga Insights
Friday, August 04, 2023
Exagen's Earnings Outlook
Benzinga Insights
Thursday, July 27, 2023
Board Member at Exagen Acquires Company Stock Options Worth 15,000 Shares
Benzinga Insights
Tuesday, May 16, 2023
Exagen shares are trading higher after the co...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
